Global CAR T-Cell-Based Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global CAR T-Cell-Based Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report is a detailed and comprehensive analysis for global CAR T-Cell-Based Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global CAR T-Cell-Based Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global CAR T-Cell-Based Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global CAR T-Cell-Based Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global CAR T-Cell-Based Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR T-Cell-Based Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR T-Cell-Based Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J and JW Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
CAR T-Cell-Based Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe CAR T-Cell-Based Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-Cell-Based Drug, with revenue, gross margin and global market share of CAR T-Cell-Based Drug from 2018 to 2023.
Chapter 3, the CAR T-Cell-Based Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CAR T-Cell-Based Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-Cell-Based Drug.
Chapter 13, to describe CAR T-Cell-Based Drug research findings and conclusion.
Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report is a detailed and comprehensive analysis for global CAR T-Cell-Based Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global CAR T-Cell-Based Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global CAR T-Cell-Based Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global CAR T-Cell-Based Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global CAR T-Cell-Based Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CAR T-Cell-Based Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CAR T-Cell-Based Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J and JW Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
CAR T-Cell-Based Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- CD19-targeted
- BCMA-targeted
- Lymphoma
- Multiple Myeloma
- Novartis
- Gilead Sciences
- Bristol-Myers Squibb
- J & J
- JW Therapeutics
- FOSUNKite
- CARsgen Therapeutics
- Autolus Therapeutics
- Sorrento Therapeutics
- Mustang Bio
- Bluebird Bio
- Cellectis
- Allogene Therapeutics
- Celyad
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe CAR T-Cell-Based Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CAR T-Cell-Based Drug, with revenue, gross margin and global market share of CAR T-Cell-Based Drug from 2018 to 2023.
Chapter 3, the CAR T-Cell-Based Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CAR T-Cell-Based Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of CAR T-Cell-Based Drug.
Chapter 13, to describe CAR T-Cell-Based Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of CAR T-Cell-Based Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CAR T-Cell-Based Drug by Type
1.3.1 Overview: Global CAR T-Cell-Based Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global CAR T-Cell-Based Drug Consumption Value Market Share by Type in 2022
1.3.3 CD19-targeted
1.3.4 BCMA-targeted
1.4 Global CAR T-Cell-Based Drug Market by Application
1.4.1 Overview: Global CAR T-Cell-Based Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Lymphoma
1.4.3 Multiple Myeloma
1.5 Global CAR T-Cell-Based Drug Market Size & Forecast
1.6 Global CAR T-Cell-Based Drug Market Size and Forecast by Region
1.6.1 Global CAR T-Cell-Based Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global CAR T-Cell-Based Drug Market Size by Region, (2018-2029)
1.6.3 North America CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.4 Europe CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.6 South America CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis CAR T-Cell-Based Drug Product and Solutions
2.1.4 Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR T-Cell-Based Drug Product and Solutions
2.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Solutions
2.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 J & J
2.4.1 J & J Details
2.4.2 J & J Major Business
2.4.3 J & J CAR T-Cell-Based Drug Product and Solutions
2.4.4 J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 J & J Recent Developments and Future Plans
2.5 JW Therapeutics
2.5.1 JW Therapeutics Details
2.5.2 JW Therapeutics Major Business
2.5.3 JW Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 JW Therapeutics Recent Developments and Future Plans
2.6 FOSUNKite
2.6.1 FOSUNKite Details
2.6.2 FOSUNKite Major Business
2.6.3 FOSUNKite CAR T-Cell-Based Drug Product and Solutions
2.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FOSUNKite Recent Developments and Future Plans
2.7 CARsgen Therapeutics
2.7.1 CARsgen Therapeutics Details
2.7.2 CARsgen Therapeutics Major Business
2.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CARsgen Therapeutics Recent Developments and Future Plans
2.8 Autolus Therapeutics
2.8.1 Autolus Therapeutics Details
2.8.2 Autolus Therapeutics Major Business
2.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Autolus Therapeutics Recent Developments and Future Plans
2.9 Sorrento Therapeutics
2.9.1 Sorrento Therapeutics Details
2.9.2 Sorrento Therapeutics Major Business
2.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
2.10 Mustang Bio
2.10.1 Mustang Bio Details
2.10.2 Mustang Bio Major Business
2.10.3 Mustang Bio CAR T-Cell-Based Drug Product and Solutions
2.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mustang Bio Recent Developments and Future Plans
2.11 Bluebird Bio
2.11.1 Bluebird Bio Details
2.11.2 Bluebird Bio Major Business
2.11.3 Bluebird Bio CAR T-Cell-Based Drug Product and Solutions
2.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bluebird Bio Recent Developments and Future Plans
2.12 Cellectis
2.12.1 Cellectis Details
2.12.2 Cellectis Major Business
2.12.3 Cellectis CAR T-Cell-Based Drug Product and Solutions
2.12.4 Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cellectis Recent Developments and Future Plans
2.13 Allogene Therapeutics
2.13.1 Allogene Therapeutics Details
2.13.2 Allogene Therapeutics Major Business
2.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Allogene Therapeutics Recent Developments and Future Plans
2.14 Celyad
2.14.1 Celyad Details
2.14.2 Celyad Major Business
2.14.3 Celyad CAR T-Cell-Based Drug Product and Solutions
2.14.4 Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Celyad Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global CAR T-Cell-Based Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of CAR T-Cell-Based Drug by Company Revenue
3.2.2 Top 3 CAR T-Cell-Based Drug Players Market Share in 2022
3.2.3 Top 6 CAR T-Cell-Based Drug Players Market Share in 2022
3.3 CAR T-Cell-Based Drug Market: Overall Company Footprint Analysis
3.3.1 CAR T-Cell-Based Drug Market: Region Footprint
3.3.2 CAR T-Cell-Based Drug Market: Company Product Type Footprint
3.3.3 CAR T-Cell-Based Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global CAR T-Cell-Based Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global CAR T-Cell-Based Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global CAR T-Cell-Based Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
6.2 North America CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
6.3 North America CAR T-Cell-Based Drug Market Size by Country
6.3.1 North America CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
6.3.2 United States CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
6.3.3 Canada CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
7.2 Europe CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
7.3 Europe CAR T-Cell-Based Drug Market Size by Country
7.3.1 Europe CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
7.3.2 Germany CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.3 France CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.5 Russia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.6 Italy CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region
8.3.1 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Region (2018-2029)
8.3.2 China CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.3 Japan CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.5 India CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.7 Australia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
9.2 South America CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
9.3 South America CAR T-Cell-Based Drug Market Size by Country
9.3.1 South America CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country
10.3.1 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
10.3.4 UAE CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 CAR T-Cell-Based Drug Market Drivers
11.2 CAR T-Cell-Based Drug Market Restraints
11.3 CAR T-Cell-Based Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 CAR T-Cell-Based Drug Industry Chain
12.2 CAR T-Cell-Based Drug Upstream Analysis
12.3 CAR T-Cell-Based Drug Midstream Analysis
12.4 CAR T-Cell-Based Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of CAR T-Cell-Based Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of CAR T-Cell-Based Drug by Type
1.3.1 Overview: Global CAR T-Cell-Based Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global CAR T-Cell-Based Drug Consumption Value Market Share by Type in 2022
1.3.3 CD19-targeted
1.3.4 BCMA-targeted
1.4 Global CAR T-Cell-Based Drug Market by Application
1.4.1 Overview: Global CAR T-Cell-Based Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Lymphoma
1.4.3 Multiple Myeloma
1.5 Global CAR T-Cell-Based Drug Market Size & Forecast
1.6 Global CAR T-Cell-Based Drug Market Size and Forecast by Region
1.6.1 Global CAR T-Cell-Based Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global CAR T-Cell-Based Drug Market Size by Region, (2018-2029)
1.6.3 North America CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.4 Europe CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.6 South America CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis CAR T-Cell-Based Drug Product and Solutions
2.1.4 Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences CAR T-Cell-Based Drug Product and Solutions
2.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Solutions
2.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.4 J & J
2.4.1 J & J Details
2.4.2 J & J Major Business
2.4.3 J & J CAR T-Cell-Based Drug Product and Solutions
2.4.4 J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 J & J Recent Developments and Future Plans
2.5 JW Therapeutics
2.5.1 JW Therapeutics Details
2.5.2 JW Therapeutics Major Business
2.5.3 JW Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 JW Therapeutics Recent Developments and Future Plans
2.6 FOSUNKite
2.6.1 FOSUNKite Details
2.6.2 FOSUNKite Major Business
2.6.3 FOSUNKite CAR T-Cell-Based Drug Product and Solutions
2.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FOSUNKite Recent Developments and Future Plans
2.7 CARsgen Therapeutics
2.7.1 CARsgen Therapeutics Details
2.7.2 CARsgen Therapeutics Major Business
2.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 CARsgen Therapeutics Recent Developments and Future Plans
2.8 Autolus Therapeutics
2.8.1 Autolus Therapeutics Details
2.8.2 Autolus Therapeutics Major Business
2.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Autolus Therapeutics Recent Developments and Future Plans
2.9 Sorrento Therapeutics
2.9.1 Sorrento Therapeutics Details
2.9.2 Sorrento Therapeutics Major Business
2.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
2.10 Mustang Bio
2.10.1 Mustang Bio Details
2.10.2 Mustang Bio Major Business
2.10.3 Mustang Bio CAR T-Cell-Based Drug Product and Solutions
2.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mustang Bio Recent Developments and Future Plans
2.11 Bluebird Bio
2.11.1 Bluebird Bio Details
2.11.2 Bluebird Bio Major Business
2.11.3 Bluebird Bio CAR T-Cell-Based Drug Product and Solutions
2.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bluebird Bio Recent Developments and Future Plans
2.12 Cellectis
2.12.1 Cellectis Details
2.12.2 Cellectis Major Business
2.12.3 Cellectis CAR T-Cell-Based Drug Product and Solutions
2.12.4 Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cellectis Recent Developments and Future Plans
2.13 Allogene Therapeutics
2.13.1 Allogene Therapeutics Details
2.13.2 Allogene Therapeutics Major Business
2.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product and Solutions
2.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Allogene Therapeutics Recent Developments and Future Plans
2.14 Celyad
2.14.1 Celyad Details
2.14.2 Celyad Major Business
2.14.3 Celyad CAR T-Cell-Based Drug Product and Solutions
2.14.4 Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Celyad Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global CAR T-Cell-Based Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of CAR T-Cell-Based Drug by Company Revenue
3.2.2 Top 3 CAR T-Cell-Based Drug Players Market Share in 2022
3.2.3 Top 6 CAR T-Cell-Based Drug Players Market Share in 2022
3.3 CAR T-Cell-Based Drug Market: Overall Company Footprint Analysis
3.3.1 CAR T-Cell-Based Drug Market: Region Footprint
3.3.2 CAR T-Cell-Based Drug Market: Company Product Type Footprint
3.3.3 CAR T-Cell-Based Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global CAR T-Cell-Based Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global CAR T-Cell-Based Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global CAR T-Cell-Based Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
6.2 North America CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
6.3 North America CAR T-Cell-Based Drug Market Size by Country
6.3.1 North America CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
6.3.2 United States CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
6.3.3 Canada CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
7.2 Europe CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
7.3 Europe CAR T-Cell-Based Drug Market Size by Country
7.3.1 Europe CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
7.3.2 Germany CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.3 France CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.5 Russia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
7.3.6 Italy CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region
8.3.1 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Region (2018-2029)
8.3.2 China CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.3 Japan CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.5 India CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
8.3.7 Australia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
9.2 South America CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
9.3 South America CAR T-Cell-Based Drug Market Size by Country
9.3.1 South America CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country
10.3.1 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
10.3.4 UAE CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 CAR T-Cell-Based Drug Market Drivers
11.2 CAR T-Cell-Based Drug Market Restraints
11.3 CAR T-Cell-Based Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 CAR T-Cell-Based Drug Industry Chain
12.2 CAR T-Cell-Based Drug Upstream Analysis
12.3 CAR T-Cell-Based Drug Midstream Analysis
12.4 CAR T-Cell-Based Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global CAR T-Cell-Based Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CAR T-Cell-Based Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global CAR T-Cell-Based Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global CAR T-Cell-Based Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis CAR T-Cell-Based Drug Product and Solutions
Table 8. Novartis CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences CAR T-Cell-Based Drug Product and Solutions
Table 13. Gilead Sciences CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Gilead Sciences Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Solutions
Table 18. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
Table 20. J & J Company Information, Head Office, and Major Competitors
Table 21. J & J Major Business
Table 22. J & J CAR T-Cell-Based Drug Product and Solutions
Table 23. J & J CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. J & J Recent Developments and Future Plans
Table 25. JW Therapeutics Company Information, Head Office, and Major Competitors
Table 26. JW Therapeutics Major Business
Table 27. JW Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 28. JW Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. JW Therapeutics Recent Developments and Future Plans
Table 30. FOSUNKite Company Information, Head Office, and Major Competitors
Table 31. FOSUNKite Major Business
Table 32. FOSUNKite CAR T-Cell-Based Drug Product and Solutions
Table 33. FOSUNKite CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. FOSUNKite Recent Developments and Future Plans
Table 35. CARsgen Therapeutics Company Information, Head Office, and Major Competitors
Table 36. CARsgen Therapeutics Major Business
Table 37. CARsgen Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 38. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. CARsgen Therapeutics Recent Developments and Future Plans
Table 40. Autolus Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Autolus Therapeutics Major Business
Table 42. Autolus Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 43. Autolus Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Autolus Therapeutics Recent Developments and Future Plans
Table 45. Sorrento Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Sorrento Therapeutics Major Business
Table 47. Sorrento Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 48. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sorrento Therapeutics Recent Developments and Future Plans
Table 50. Mustang Bio Company Information, Head Office, and Major Competitors
Table 51. Mustang Bio Major Business
Table 52. Mustang Bio CAR T-Cell-Based Drug Product and Solutions
Table 53. Mustang Bio CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Mustang Bio Recent Developments and Future Plans
Table 55. Bluebird Bio Company Information, Head Office, and Major Competitors
Table 56. Bluebird Bio Major Business
Table 57. Bluebird Bio CAR T-Cell-Based Drug Product and Solutions
Table 58. Bluebird Bio CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Bluebird Bio Recent Developments and Future Plans
Table 60. Cellectis Company Information, Head Office, and Major Competitors
Table 61. Cellectis Major Business
Table 62. Cellectis CAR T-Cell-Based Drug Product and Solutions
Table 63. Cellectis CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Cellectis Recent Developments and Future Plans
Table 65. Allogene Therapeutics Company Information, Head Office, and Major Competitors
Table 66. Allogene Therapeutics Major Business
Table 67. Allogene Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 68. Allogene Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Allogene Therapeutics Recent Developments and Future Plans
Table 70. Celyad Company Information, Head Office, and Major Competitors
Table 71. Celyad Major Business
Table 72. Celyad CAR T-Cell-Based Drug Product and Solutions
Table 73. Celyad CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Celyad Recent Developments and Future Plans
Table 75. Global CAR T-Cell-Based Drug Revenue (USD Million) by Players (2018-2023)
Table 76. Global CAR T-Cell-Based Drug Revenue Share by Players (2018-2023)
Table 77. Breakdown of CAR T-Cell-Based Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in CAR T-Cell-Based Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key CAR T-Cell-Based Drug Players
Table 80. CAR T-Cell-Based Drug Market: Company Product Type Footprint
Table 81. CAR T-Cell-Based Drug Market: Company Product Application Footprint
Table 82. CAR T-Cell-Based Drug New Market Entrants and Barriers to Market Entry
Table 83. CAR T-Cell-Based Drug Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global CAR T-Cell-Based Drug Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global CAR T-Cell-Based Drug Consumption Value Share by Type (2018-2023)
Table 86. Global CAR T-Cell-Based Drug Consumption Value Forecast by Type (2024-2029)
Table 87. Global CAR T-Cell-Based Drug Consumption Value by Application (2018-2023)
Table 88. Global CAR T-Cell-Based Drug Consumption Value Forecast by Application (2024-2029)
Table 89. North America CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 119. CAR T-Cell-Based Drug Raw Material
Table 120. Key Suppliers of CAR T-Cell-Based Drug Raw Materials
Table 1. Global CAR T-Cell-Based Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global CAR T-Cell-Based Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global CAR T-Cell-Based Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global CAR T-Cell-Based Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Novartis Company Information, Head Office, and Major Competitors
Table 6. Novartis Major Business
Table 7. Novartis CAR T-Cell-Based Drug Product and Solutions
Table 8. Novartis CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Novartis Recent Developments and Future Plans
Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences CAR T-Cell-Based Drug Product and Solutions
Table 13. Gilead Sciences CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Gilead Sciences Recent Developments and Future Plans
Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Solutions
Table 18. Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
Table 20. J & J Company Information, Head Office, and Major Competitors
Table 21. J & J Major Business
Table 22. J & J CAR T-Cell-Based Drug Product and Solutions
Table 23. J & J CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. J & J Recent Developments and Future Plans
Table 25. JW Therapeutics Company Information, Head Office, and Major Competitors
Table 26. JW Therapeutics Major Business
Table 27. JW Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 28. JW Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. JW Therapeutics Recent Developments and Future Plans
Table 30. FOSUNKite Company Information, Head Office, and Major Competitors
Table 31. FOSUNKite Major Business
Table 32. FOSUNKite CAR T-Cell-Based Drug Product and Solutions
Table 33. FOSUNKite CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. FOSUNKite Recent Developments and Future Plans
Table 35. CARsgen Therapeutics Company Information, Head Office, and Major Competitors
Table 36. CARsgen Therapeutics Major Business
Table 37. CARsgen Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 38. CARsgen Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. CARsgen Therapeutics Recent Developments and Future Plans
Table 40. Autolus Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Autolus Therapeutics Major Business
Table 42. Autolus Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 43. Autolus Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Autolus Therapeutics Recent Developments and Future Plans
Table 45. Sorrento Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Sorrento Therapeutics Major Business
Table 47. Sorrento Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 48. Sorrento Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sorrento Therapeutics Recent Developments and Future Plans
Table 50. Mustang Bio Company Information, Head Office, and Major Competitors
Table 51. Mustang Bio Major Business
Table 52. Mustang Bio CAR T-Cell-Based Drug Product and Solutions
Table 53. Mustang Bio CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Mustang Bio Recent Developments and Future Plans
Table 55. Bluebird Bio Company Information, Head Office, and Major Competitors
Table 56. Bluebird Bio Major Business
Table 57. Bluebird Bio CAR T-Cell-Based Drug Product and Solutions
Table 58. Bluebird Bio CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Bluebird Bio Recent Developments and Future Plans
Table 60. Cellectis Company Information, Head Office, and Major Competitors
Table 61. Cellectis Major Business
Table 62. Cellectis CAR T-Cell-Based Drug Product and Solutions
Table 63. Cellectis CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Cellectis Recent Developments and Future Plans
Table 65. Allogene Therapeutics Company Information, Head Office, and Major Competitors
Table 66. Allogene Therapeutics Major Business
Table 67. Allogene Therapeutics CAR T-Cell-Based Drug Product and Solutions
Table 68. Allogene Therapeutics CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Allogene Therapeutics Recent Developments and Future Plans
Table 70. Celyad Company Information, Head Office, and Major Competitors
Table 71. Celyad Major Business
Table 72. Celyad CAR T-Cell-Based Drug Product and Solutions
Table 73. Celyad CAR T-Cell-Based Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Celyad Recent Developments and Future Plans
Table 75. Global CAR T-Cell-Based Drug Revenue (USD Million) by Players (2018-2023)
Table 76. Global CAR T-Cell-Based Drug Revenue Share by Players (2018-2023)
Table 77. Breakdown of CAR T-Cell-Based Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in CAR T-Cell-Based Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key CAR T-Cell-Based Drug Players
Table 80. CAR T-Cell-Based Drug Market: Company Product Type Footprint
Table 81. CAR T-Cell-Based Drug Market: Company Product Application Footprint
Table 82. CAR T-Cell-Based Drug New Market Entrants and Barriers to Market Entry
Table 83. CAR T-Cell-Based Drug Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global CAR T-Cell-Based Drug Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global CAR T-Cell-Based Drug Consumption Value Share by Type (2018-2023)
Table 86. Global CAR T-Cell-Based Drug Consumption Value Forecast by Type (2024-2029)
Table 87. Global CAR T-Cell-Based Drug Consumption Value by Application (2018-2023)
Table 88. Global CAR T-Cell-Based Drug Consumption Value Forecast by Application (2024-2029)
Table 89. North America CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 119. CAR T-Cell-Based Drug Raw Material
Table 120. Key Suppliers of CAR T-Cell-Based Drug Raw Materials
LIST OF FIGURES
Figure 1. CAR T-Cell-Based Drug Picture
Figure 2. Global CAR T-Cell-Based Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CAR T-Cell-Based Drug Consumption Value Market Share by Type in 2022
Figure 4. CD19-targeted
Figure 5. BCMA-targeted
Figure 6. Global CAR T-Cell-Based Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. CAR T-Cell-Based Drug Consumption Value Market Share by Application in 2022
Figure 8. Lymphoma Picture
Figure 9. Multiple Myeloma Picture
Figure 10. Global CAR T-Cell-Based Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global CAR T-Cell-Based Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market CAR T-Cell-Based Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global CAR T-Cell-Based Drug Consumption Value Market Share by Region (2018-2029)
Figure 14. Global CAR T-Cell-Based Drug Consumption Value Market Share by Region in 2022
Figure 15. North America CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. South America CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Global CAR T-Cell-Based Drug Revenue Share by Players in 2022
Figure 21. CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players CAR T-Cell-Based Drug Market Share in 2022
Figure 23. Global Top 6 Players CAR T-Cell-Based Drug Market Share in 2022
Figure 24. Global CAR T-Cell-Based Drug Consumption Value Share by Type (2018-2023)
Figure 25. Global CAR T-Cell-Based Drug Market Share Forecast by Type (2024-2029)
Figure 26. Global CAR T-Cell-Based Drug Consumption Value Share by Application (2018-2023)
Figure 27. Global CAR T-Cell-Based Drug Market Share Forecast by Application (2024-2029)
Figure 28. North America CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. North America CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 30. North America CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 31. United States CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. France CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific CAR T-Cell-Based Drug Consumption Value Market Share by Region (2018-2029)
Figure 45. China CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. India CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South America CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 52. South America CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 53. South America CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. CAR T-Cell-Based Drug Market Drivers
Figure 63. CAR T-Cell-Based Drug Market Restraints
Figure 64. CAR T-Cell-Based Drug Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of CAR T-Cell-Based Drug in 2022
Figure 67. Manufacturing Process Analysis of CAR T-Cell-Based Drug
Figure 68. CAR T-Cell-Based Drug Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. CAR T-Cell-Based Drug Picture
Figure 2. Global CAR T-Cell-Based Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global CAR T-Cell-Based Drug Consumption Value Market Share by Type in 2022
Figure 4. CD19-targeted
Figure 5. BCMA-targeted
Figure 6. Global CAR T-Cell-Based Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. CAR T-Cell-Based Drug Consumption Value Market Share by Application in 2022
Figure 8. Lymphoma Picture
Figure 9. Multiple Myeloma Picture
Figure 10. Global CAR T-Cell-Based Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global CAR T-Cell-Based Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market CAR T-Cell-Based Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global CAR T-Cell-Based Drug Consumption Value Market Share by Region (2018-2029)
Figure 14. Global CAR T-Cell-Based Drug Consumption Value Market Share by Region in 2022
Figure 15. North America CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. South America CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Global CAR T-Cell-Based Drug Revenue Share by Players in 2022
Figure 21. CAR T-Cell-Based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players CAR T-Cell-Based Drug Market Share in 2022
Figure 23. Global Top 6 Players CAR T-Cell-Based Drug Market Share in 2022
Figure 24. Global CAR T-Cell-Based Drug Consumption Value Share by Type (2018-2023)
Figure 25. Global CAR T-Cell-Based Drug Market Share Forecast by Type (2024-2029)
Figure 26. Global CAR T-Cell-Based Drug Consumption Value Share by Application (2018-2023)
Figure 27. Global CAR T-Cell-Based Drug Market Share Forecast by Application (2024-2029)
Figure 28. North America CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. North America CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 30. North America CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 31. United States CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. France CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific CAR T-Cell-Based Drug Consumption Value Market Share by Region (2018-2029)
Figure 45. China CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. India CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South America CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 52. South America CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 53. South America CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa CAR T-Cell-Based Drug Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa CAR T-Cell-Based Drug Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE CAR T-Cell-Based Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. CAR T-Cell-Based Drug Market Drivers
Figure 63. CAR T-Cell-Based Drug Market Restraints
Figure 64. CAR T-Cell-Based Drug Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of CAR T-Cell-Based Drug in 2022
Figure 67. Manufacturing Process Analysis of CAR T-Cell-Based Drug
Figure 68. CAR T-Cell-Based Drug Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
